Table 3.
On‐Treatment Laboratory Abnormalitiesa
| Parameter, n (%) |
Glecaprevir/Pibrentasvir (N = 100) |
|---|---|
| Platelets (<50 × 109/L) | 1 (1) |
| INR (>2.5 × ULN) | 1 (1) |
| Alanine aminotransferase (>5 × ULN) | 1 (1) |
| Total bilirubin (>3 × ULN) | 1 (1) |
| Creatinine clearance (<30 mL/min) | 2 (2) |
a
Numbers and percentages of patients who experienced grade 3 or 4 (Common Terminology Criteria for Adverse Events) worsening of laboratory values from baseline are shown.
Abbreviations: INR, international normalized ratio; ULN, upper limit of normal.